- Dose range
- 200-500 mcg/day
- Route
- Subcutaneous injection or oral
- Indication(s)
- Anti-inflammatory tripeptide; gut and skin inflammation
Titration schedule
| Step | Dose | Duration | Notes |
|---|---|---|---|
| - | 200-500 mcg | Daily | SC or oral; anti-inflammatory |
Important notes
- This research compound dosing chart is intended as a reference for clinicians and patients reviewing protocols, not a substitute for individualized prescriber guidance.
- Research compound; not FDA-approved for any indication. Off-label or experimental use only.
- Compounded versions, where applicable, must be prepared by a licensed 503A or 503B compounding pharmacy. The April 14, 2026 FDA action restricted salt-form active ingredients.
References
- KPV (Lys-Pro-Val) prescribing information / clinical literature.
- FDA Section 503A Interim Bulk Drug Substances List, updated April 14, 2026.
- USP <797>: Pharmaceutical Compounding — Sterile Preparations.